Celldex Therapeutics, Inc. · NASDAQ:CLDX
The Vanguard Group's stake in Celldex Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Mar 13, 2026 · Filed Mar 26, 2026
The Vanguard Group's stake in Celldex Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Mar 13, 2026. Filed Mar 26, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 0% | 0 |
Source
Related
- Celldex Therapeutics, Inc.
- The Vanguard Group
- Celldex Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · May 15, 2026
- Schedule 13G/A · Kynam Capital Management, LP · May 15, 2026